DMK PHARMACEUTICALS CORPORATION: cashflow_investing
| Value | {"amount": 3483909, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2022-01-01 – 2022-12-31 |
| Status | current |
| Entity | DMK PHARMACEUTICALS CORPORATION |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:54:25.189173+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/1fb2813e-a755-4da2-a879-e7dcee177047
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001387131-23-003523 · Open the official SEC filing →Retrieved: 2026-08-19T08:54:25.189173+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000887247/cashflow-investing/2022-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/1fb2813e-a755-4da2-a879-e7dcee177047
History
- no predecessors — first report